Drug: Doribax (doripenem)
Indication: Urrinary tract infections
Company: Johnson & Johnson
Approval Date: October 12, 2007
Scoop: DORIBAX belongs to a class of antibacterial agents called carbapenems, which are important for treating serious infections caused by Gram-positive and Gram-negative bacteria. The drug is approved for complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis.
Links:
[1] http://www.fiercebiotech.com/special-reports/somatuline-depot-2007-fda-approvals
[2] http://www.fiercebiotech.com/special-reports/2007-fda-approvals
[3] http://www.fiercebiotech.com/special-reports/isentress-2007-fda-approvals